[PHAS] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
13-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 9.93%
YoY- -83.55%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 158 335 10,338 0 0 241 703 -62.93%
PBT 86,232 -31,924 -27,079 -27,358 -30,375 -25,143 -28,142 -
Tax -1,598 -3,126 1,600 -1,426 -4,071 -4,289 -3,665 -42.41%
NP 87,830 -31,924 -28,679 -27,358 -30,375 -25,143 -28,142 -
Tax Rate 1.85% - - - - - - -
Total Cost -87,672 32,259 39,017 27,358 30,375 25,384 28,845 -
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 55,588.56 -9,529.55 -277.41 0.00 -9,492,187,500,000,000.00 -10,432.78 -4,003.13 -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS 1.82 -0.66 -0.60 -0.87 -1.03 -0.86 -0.98 -
EPS Diluted 1.82 -0.66 -0.60 -0.87 -1.03 -0.86 -0.98 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.